Women who begin hormone replacement therapy (HRT) during a specific timeframe in midlife may lower their risk of developing dementia in later years, according to major new research.
A team led by the University of East Anglia and the University of Exeter examined medical data from more than 183,000 post-menopausal participants enrolled in the UK Biobank project.